Home Authors Posts by Iris Dorbian

Iris Dorbian

SynapDx Corp. said Monday that it has raised $15.4 million in funding. The lead investor was Google Ventures. Foundation Medical Partners also participated in the round as did existing investors North Bridge Venture Partners and General Catalyst Partners. In addition to the funding, SynapDx has named Google’s Andrew Conrad, PhD, to the company's board. Based in Lexington, Mass., SynapDx is a provider of diagnostic services for autism and neurodevelopmental disorders.
Maker’s Row said Friday that it has raised $1 million in seed funding. Comcast Ventures and Index Ventures were the co-lead investors. Headquartered in Brooklyn, NY, Maker's Row is a marketplace that connects American manufacturers with businesses.
Objective Logistics said Thursday that it has received $5.3 million in Series A funding. Atlas Venture led the round with participation from Google Ventures and Next View Ventures. The Massachusetts-based Objective Logistics is a provider of software solutions in the workforce.
Kapost said Thursday that it has raised $5.6 in funding. The lead investors were Lead Edge Capital and Floodgate. Existing investor High Country Venture also participated in the round. Based in Boulder, Colorado, Kapost is a content marketing software platform.
Audentes Therapeutics said Thursday that it has secured $30 million in Series A financing. The lead investor was OrbiMed Advisors. Versant Ventures and 5AM Ventures also participated in the round. Also, Jonathan Silverstein of OrbiMed Advisors, has been named chairman of Audentes' board. Headquartered in San Francisco, Calif., Audentes Therapeutics is a biotechnology company.
VelociData said Thursday that it has raised $10 million in financing. Motorola Chairman and CEO Christopher Galvin was the lead investor. Founding investors Bush O’Donnell and NewSpring Growth Capital also participated in the round. Also, Galvin joins VelociData's board of directors. Headquartered in St. Louis, Missouri, VelociData is a provider of data solutions.
Netlist said Thursday that it has secured credit financing of $15 million from an affiliate of Fortress Investment Group, a global investment firm. According to Netlist, the financing will be used for product and patent portfolios. Headquartered in Irvine, Calif., Netlist is a provider of memory solutions for the cloud computing and storage markets.
TB Biosciences said Thursday that it has raised $1.5 million in Series A financing. The lead investor was Originate Ventures. Ben Franklin Technology Partners of Northeastern Pennsylvania and the NYU Innovation Venture Fund also participated in the round. According to TB Biosciences, the funding will be used for product development and clinical trials. Based in Bethlehem, Pennsylvania, TB Biosciences is a developer of a rapid point-of-care tuberculosis test.
Cintrifuse said Thursday that its Early Stage Capital Fund I is investing in Allos Ventures Fund II and Sigma Prime IX Fund. No exact financial terms were disclosed for the two investments, however, Cintrifuse has raised $51 million for its fund. Managed by Allos Ventures, Allos II focuses on early-stage software and business technology companies while Sigma Prime IX, which is run by Sigma Prime Ventures, targets technology startups. Based in Cincinnati, The Cintrifuse Early Stage Capital Fund I is a venture capital fund of funds that invests in early-stage venture capital funds with a focus on technology, life sciences, consumer goods/services and energy.
Ioxus has raised $15 million in Series C funding. The lead investor was The Westly Group. Northwater Capital Management, Braemar Energy Ventures, Energy Technology Ventures and Aster Capital also participated in the round. According to Ioxus, the capital will be used for research and development as well as expansion. Headquartered in Oneonta, NY, Ioxus is a provider of technology for transportation, industrial and energy applications.
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination